Completed NA INTERVENTIONAL 3-arm NCT03116672

The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo (PreOp)

The Outcome of Preoperative Administration of Single-dose Ketorolac, Non-steroidal Anti-inflammatory Drug and Placebo on Postoperative Pain in Teeth With Irreversible Pulpitis and Apical Periodontitis

Sponsor: Universidad Autonoma de Baja California

Conditions Pulpitis - Irreversible

Interventions One dose Diclofenac Placebo oral capsule one dose ketorolac 10 mg

Updated 5 times since 2017 Last updated: Apr 14, 2017 Started: Feb 2, 2016 Primary completion: Feb 6, 2017 Completion: Feb 10, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03116672, this NA trial focuses on Pulpitis - Irreversible and remains completed. Sponsored by Universidad Autonoma de Baja California, it has been updated 5 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jun 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Autonoma de Baja California

Data source: Universidad Autonoma de Baja California

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tijuana, Mexico